BR9608627A - Polipeptídeo recombinante peptídeo molécula isolada de ácido nucléico vetor célula hospedeira abrigando um vetor processos para produção de um polipetídeo para eliciar em em marnífero uma resposta imune protetora e de diagnóstico in vitro da infecção pela helicobacter pylori composição de vacina uso do polipeptídeo e kit de diagnóstico - Google Patents

Polipeptídeo recombinante peptídeo molécula isolada de ácido nucléico vetor célula hospedeira abrigando um vetor processos para produção de um polipetídeo para eliciar em em marnífero uma resposta imune protetora e de diagnóstico in vitro da infecção pela helicobacter pylori composição de vacina uso do polipeptídeo e kit de diagnóstico

Info

Publication number
BR9608627A
BR9608627A BR9608627A BR9608627A BR9608627A BR 9608627 A BR9608627 A BR 9608627A BR 9608627 A BR9608627 A BR 9608627A BR 9608627 A BR9608627 A BR 9608627A BR 9608627 A BR9608627 A BR 9608627A
Authority
BR
Brazil
Prior art keywords
polypeptide
vector
elicit
nucleic acid
producing
Prior art date
Application number
BR9608627A
Other languages
English (en)
Inventor
Ann-Mari Svennerholm
Ingrid Bolin
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9502007A external-priority patent/SE9502007D0/xx
Priority claimed from SE9601085A external-priority patent/SE9601085D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of BR9608627A publication Critical patent/BR9608627A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR9608627A 1995-06-01 1996-06-03 Polipeptídeo recombinante peptídeo molécula isolada de ácido nucléico vetor célula hospedeira abrigando um vetor processos para produção de um polipetídeo para eliciar em em marnífero uma resposta imune protetora e de diagnóstico in vitro da infecção pela helicobacter pylori composição de vacina uso do polipeptídeo e kit de diagnóstico BR9608627A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9502007A SE9502007D0 (sv) 1995-06-01 1995-06-01 Novel polypeptides
SE9601085A SE9601085D0 (sv) 1996-03-21 1996-03-21 Novel polypeptides
PCT/SE1996/000727 WO1996038475A1 (en) 1995-06-01 1996-06-03 Helicobacter pylori antigens and vaccine compositions

Publications (1)

Publication Number Publication Date
BR9608627A true BR9608627A (pt) 1999-06-15

Family

ID=26662316

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608627A BR9608627A (pt) 1995-06-01 1996-06-03 Polipeptídeo recombinante peptídeo molécula isolada de ácido nucléico vetor célula hospedeira abrigando um vetor processos para produção de um polipetídeo para eliciar em em marnífero uma resposta imune protetora e de diagnóstico in vitro da infecção pela helicobacter pylori composição de vacina uso do polipeptídeo e kit de diagnóstico

Country Status (22)

Country Link
US (2) US6025164A (pt)
EP (1) EP0828757A1 (pt)
JP (1) JP3380559B2 (pt)
KR (1) KR19990022131A (pt)
CN (1) CN1191544A (pt)
AR (1) AR003125A1 (pt)
BR (1) BR9608627A (pt)
CA (1) CA2222797A1 (pt)
CZ (1) CZ357397A3 (pt)
EE (1) EE9700306A (pt)
HU (1) HUP9901546A3 (pt)
IL (1) IL122340A0 (pt)
IS (1) IS4615A (pt)
MY (1) MY119003A (pt)
NO (1) NO975490L (pt)
NZ (1) NZ303356A (pt)
PL (1) PL323741A1 (pt)
RU (1) RU2195463C2 (pt)
SK (1) SK155297A3 (pt)
TR (1) TR199701471T1 (pt)
TW (1) TW570925B (pt)
WO (1) WO1996038475A1 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
WO1995014093A1 (en) 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
KR100333113B1 (ko) * 1993-07-27 2002-11-27 시에스엘 리미티드 헬리코박터피롤리관련위십이지장질환의치료방법
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
HUP9900766A3 (en) * 1995-06-07 2002-08-28 Astra Ab Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics
EP0971734A4 (en) * 1997-03-26 2001-02-07 Avant Immunotherapeutics Inc CARBOHYDRATE ANTIGENS HAVING IMMUNOLOGICAL REACTIVITY WITH POLYCLONAL ANTISERUMS AGAINST H. PYLORI
CA2289253A1 (en) * 1997-04-30 1998-11-05 Merieux Oravax Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method
SE9702242D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions V
SE9702241D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions IV
US7393529B2 (en) 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
SE9801288D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
JP4346821B2 (ja) * 1998-04-30 2009-10-21 カイロン ソチエタ ア レスポンサビリタ リミタータ Ｈ．Ｐｙｌｏｒｉによる感染に対する免疫化および処置
WO2000049044A1 (en) * 1999-02-19 2000-08-24 Astrazeneca Ab Expression of helicobacter polypeptides in pichia pastoris
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
WO2001083531A1 (en) * 2000-04-27 2001-11-08 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Method for identifying helicobacter antigens
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
EP1660524B1 (en) 2003-08-15 2011-01-12 University of Florida Research Foundation, Inc. Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
US7381547B2 (en) * 2004-04-28 2008-06-03 Tzam Diagnostics, Llc Methods and compositions to detect bacteria using multiplex PCR
KR100613924B1 (ko) * 2004-06-23 2006-08-21 현대자동차주식회사 자동차 연료 시스템
WO2007014179A2 (en) * 2005-07-25 2007-02-01 University Of Rochester Method for controlling immunodominance
CN101784655A (zh) * 2007-04-27 2010-07-21 菲尼克斯股份有限公司 可溶性重组二十面体病毒样颗粒的改良生成和体内装配
CN101496898B (zh) * 2009-02-16 2011-06-15 中国人民解放军军事医学科学院生物工程研究所 一种预防和/或治疗幽门螺杆菌感染的疫苗
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования
BR112018012033A2 (pt) 2015-12-14 2018-12-04 Max Planck Gesellschaft composição imunogênica e método para detectar infecção por h. pylori em um sujeito
US10577409B2 (en) * 2016-05-26 2020-03-03 Sagabio Co., Ltd. Monoclonal antibody inhibiting immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibody
CN107456578A (zh) * 2016-06-03 2017-12-12 硕英生医股份有限公司 一种关闭病原体的免疫抑制功能的方法及其用途
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
CN111467368B (zh) * 2020-04-13 2021-05-28 江南大学 含庚糖链的寡糖化合物在制备幽门螺旋杆菌疫苗中的应用
CN113144182B (zh) * 2021-04-22 2023-03-10 成都欧林生物科技股份有限公司 一种幽门螺杆菌口服缓释疫苗及其制备与应用
CN113896775A (zh) * 2021-08-25 2022-01-07 河北医科大学第四医院 幽门螺杆菌特异性免疫原性肽段

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU648251B2 (en) * 1989-03-09 1994-04-21 Wyeth Holdings Corporation Vaccines for nontypable haemophilus influenzae
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US5420014A (en) * 1992-04-30 1995-05-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva

Also Published As

Publication number Publication date
HUP9901546A3 (en) 2003-07-28
NO975490D0 (no) 1997-11-28
TW570925B (en) 2004-01-11
AU703331B2 (en) 1999-03-25
JP3380559B2 (ja) 2003-02-24
RU2195463C2 (ru) 2002-12-27
NO975490L (no) 1998-01-07
TR199701471T1 (xx) 1998-02-21
CN1191544A (zh) 1998-08-26
PL323741A1 (en) 1998-04-14
NZ303356A (en) 1999-05-28
EP0828757A1 (en) 1998-03-18
IL122340A0 (en) 1998-04-05
JPH11507210A (ja) 1999-06-29
CZ357397A3 (cs) 1998-05-13
KR19990022131A (ko) 1999-03-25
US6025164A (en) 2000-02-15
EE9700306A (xx) 1998-06-15
MY119003A (en) 2005-03-31
HUP9901546A2 (hu) 1999-08-30
IS4615A (is) 1997-11-17
AU6020596A (en) 1996-12-18
WO1996038475A1 (en) 1996-12-05
AR003125A1 (es) 1998-07-08
SK155297A3 (en) 1998-08-05
CA2222797A1 (en) 1996-12-05
MX9709194A (es) 1998-07-31
US20020168726A1 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
BR9608627A (pt) Polipeptídeo recombinante peptídeo molécula isolada de ácido nucléico vetor célula hospedeira abrigando um vetor processos para produção de um polipetídeo para eliciar em em marnífero uma resposta imune protetora e de diagnóstico in vitro da infecção pela helicobacter pylori composição de vacina uso do polipeptídeo e kit de diagnóstico
CA2123580A1 (en) Antigen of hybrid m protein and carrier for group a streptococcal vaccine
IT1153265B (it) Polipeptidi contenenti la sequenza degli amminoacidi dell'interferone umano immune (interferone umano gamma), relativi veicoli di espressione, loro procedimento di preparazione, composizioni farmaceutiche contenenti tali polipeptidi
AR017866A1 (es) Metodo para incrementar las inmunorespuestas de vacunas de acidos nucleicos, composiciones farmaceuticas de aplicacion en dicho metodo, procedimientopara preparar dichas composiciones y vacunas utilizadas en dicho metodo.
BR9809445A (pt) Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico.
BR9307510A (pt) Molécula de ácido nucleico purificada e isolada plasmídeo recombinante adaptado para transformação de hospedeiro vector recombinante adaptado para transformação de célula hospedeira proteína purificada e isolada proteína de membrana externa d15 peptídio sintético molécula quimérica composição imunogênica e anti-soro ou anticorpo
WO2000034317A3 (en) Method for reducing immunogenicity of proteins
CA2228221A1 (en) Papillomavirus polyprotein constructs
NO20011381L (no) Preparater av streptokokk C<beta>-protein
DK64185D0 (da) Peptider, farmaceutiske praeparater, gener, vektorer, vaertsorganismer,fremgangsmaader til deres fremstilling og diagnostiske reagenser
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
BR9909097A (pt) Molécula hìbrida de ácido nucleico, vetor de expressão, processos para preparação e para a produção de proteìna psaa lipidada recombinante, proteìna psaa lipidada isolada e purificada produzida recombinantemente, composição imunológica, processos para induzir uma resposta imunológica em um animal e para imunizar um hospedeiro contra infecção pneumocócica, e, composição imunogênica para administração intranasal a um hospedeiro
AR009600A1 (es) Secuencia de acido nucleico y aminoacidos relacionados con helicobacter pylori y composiciones de vacuna de la misma.
DE3380629D1 (en) Region-specific determinants for vitamin k dependent bone protein
OA08354A (en) Monoclonal antibodies and antigens for human non-small cell lung carcimonas.
AU6698786A (en) Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses
BR9714133A (pt) ácido nucleico isolado, molécula do mesmo, sonda, vetor de expressão recombinante, célula, polipeptìdeo, proteìna de fusão formulação de vacina e processos para produzir um polipeptìdeo de h. pylori, para detctar a presença de um ácido nucleico de helicobacter em uma amostra, para tratar ou reduzir um risco de infecção por h. pylori em um indivìduo e para produzir uma formulação de vacina
SE9604296D0 (sv) New pharmaceutical formulation of polypeptides
NZ507983A (en) A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
KR860008270A (ko) α-인터페론의 제조 및 정제 방법
CA2006587A1 (en) Membrane proteins and peptides of haemophilus influenzae type b
GB2176191A (en) Antigens of plasmodium falciparum
Kurano et al. Total synthesis of porcine cholecystokinin-33 (CCK-33)
GR3035006T3 (en) New conjugates, consisting of a glycoprotein and a nucleic acid-binding substance.
Augustyniak et al. Characterization of glycopeptides derived from the low-density lipoprotein of hen's egg yolk

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements